Cameron Donnie, Welch Ailsa A, Adelnia Fatemeh, Bergeron Christopher M, Reiter David A, Dominguez Ligia J, Brennan Nicholas A, Fishbein Kenneth W, Spencer Richard G, Ferrucci Luigi
Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, United States.
Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
Front Physiol. 2019 Nov 27;10:1454. doi: 10.3389/fphys.2019.01454. eCollection 2019.
Total serum magnesium is a common clinical measurement for assessing magnesium status; however, magnesium in blood represents less than 1% of the body's total magnesium content. We measured intramuscular ionized magnesium by phosphorus magnetic resonance spectroscopy (P-MRS) and tested the hypothesis that this measure better correlates with skeletal muscle function and captures more closely the effect of aging than the traditional measure of total serum magnesium. Data were collected from 441 participants (age 24-98 years) in the Baltimore Longitudinal Study of Aging (BLSA), a study of normative aging that encompasses a broad age range. Results showed that intramuscular ionized magnesium was negatively associated with age (β = -0.29, < 0.001, = 0.08) and positively associated with knee-extension strength (β = 0.31, < 0.001, and = 0.1 in women; and β = 0.2, = 0.003, and = 0.04 in men), while total serum magnesium showed no association with age or strength ( = 0.27 and 0.1, respectively). Intramuscular ionized magnesium was significantly lower in women that in men ( < 0.001), perhaps due to chronic latent Mg deficiency in women that is not otherwise detected by serum magnesium levels. Based on these findings, we suggest that intramuscular ionized magnesium from P-MRS is a better clinical measure of magnesium status than total serum magnesium, and could be measured when muscle weakness of unidentified etiology is detected. It may also be used to monitor the effectiveness of oral magnesium interventions, including supplementation.
血清总镁是评估镁状态的常见临床指标;然而,血液中的镁占人体总镁含量不到1%。我们通过磷磁共振波谱法(P-MRS)测量了肌肉内离子化镁,并检验了这样一个假设:与传统的血清总镁测量方法相比,该指标与骨骼肌功能的相关性更好,且能更准确地反映衰老的影响。数据来自巴尔的摩纵向衰老研究(BLSA)中的441名参与者(年龄在24至98岁之间),这是一项涵盖广泛年龄范围的正常衰老研究。结果显示,肌肉内离子化镁与年龄呈负相关(β = -0.29,P < 0.001,r² = 0.08),与膝关节伸展力量呈正相关(女性中β = 0.31,P < 0.001,r² = 0.1;男性中β = 0.2,P = 0.003,r² = 0.04),而血清总镁与年龄或力量均无关联(P分别为0.27和0.1)。女性的肌肉内离子化镁显著低于男性(P < 0.001),这可能是由于女性存在慢性潜在镁缺乏,而血清镁水平无法检测到这种情况。基于这些发现,我们认为,P-MRS测量的肌肉内离子化镁是比血清总镁更好的镁状态临床指标,在检测到不明病因的肌肉无力时可以进行测量。它还可用于监测口服镁干预措施(包括补充剂)的效果。